Our Research Publications

Updated November 2023

Title Authors Year Journal Link to Article Intended Audience Purpose
Characterization of SHP-1 protein tyrosine phosphatase transcripts, protein isoforms and phosphatase activity in epithelial cancer cells Evren S, Wan S, Ma XZ, Fahim S, Mody N, Sakac D, Jin T, Branch DR 2013 Genomics View Researchers Basic research
Characterization of the growth dynamics and biofilm formation of Staphylococcus epidermidis strains isolated from contaminated platelet units Ali H, Greco-Stewart VS, Jacobs MR, Yomtovian RA, Rood IG, de Korte D, Ramirez-Arcos S 2014 J Med Microbiol View Blood operators Basic research
Characterization of the growth modulatory activities of osteoblast conditioned media on cord blood progenitor cells Abu-Khader A, Pasha R, Ward GCD, Boisjoli G, Pineault N 2016 Cytotechnology View Researchers Basic research
Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study Chornenki NLJ, Siegal DM, Qamar K, Woolgar S, Rangarajan S, Karampatos S, Leong DP, Hillis CM 2022 Leuk Res View Researchers Clinical research
Characterizing the ability of an ice recrystallization inhibitor to improve platelet cryopreservation Waters L, Ben R, Acker JP, Padula MP, Marks DC, Johnson L 2020 Cryobiology View Researchers New or improved product or process
Chemoenzymatic Synthesis of a Type 2 Blood Group A Tetrasaccharide and Development of High-throughput Assays Enables a Platform for Screening Blood Group Antigen-cleaving Enzymes Kwan DH, Ernst S, Kotzler MP, Withers SG 2015 Glycobiology View Researchers Basic research
Chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia Branch DR, Leger RM, Sakac d, Yi Q, Duong T, Yeung RSM, Binnington B, Bloch EM 2022 Blood Adv View Researchers Basic research
Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ?possible cohort effect following the 2009 influenza pandemic Skowronski DM, Leir S, De Serres G, Murti M, Dickinson JA, Winter A-L, Olsha R, Croxen MA, Drews SJ, Charest H, Martineau C, Sabaiduc S, Bastien N, Li Y, Petric M, Jassem A, Krajden M, Gubbay JB 2019 Euro Surveill View Health care providers Clinical research
Chloride and other electrolyte concentrations in commonly available 5% albumin products Lai AT, Zeller MP, Millen T, Kavsak P, Szczeklik W, Elahie A, Alhazzani W, D'Aragon F, Jaeschke R, Lamontagne F, Karachi T, Cook D, Meade M, Rochwerg B 2018 Crit Care Med View Researchers Clinical research
Chloride and other electrolyte concentrations in commonly available 5% albumin products Lai AT, Zeller MP, Millen T, Kavsak P, Szczeklik W, Elahie A, Alhazzani W, D'Aragon F, Jaeschke R, Lamontagne F, Karachi T, Cook D, Meade M, Rochwerg B, on behalf of The Canadian Critical Care Trials Group 2018 Crit Care Med View Health care providers Clinical research
Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis Murphy AJ, Bijl N, Yvan-Charvet L, Welch CB, Bhagwat N, Reheman A, Wang Y, Shaw JA, Levine RL, Ni H, Tall AR, Wang N 2013 Nat Med View Researchers Basic research
Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopiétiques de sang de cordon omilical Stewart T 2022 Blood.ca website View Health care providers Benchmarking and standard setting
Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopoïétiques de sang de cordon ombilical Jenkins C 2020 Blood.ca website Health care providers Benchmarking and standard setting
Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopoïétiques de sang de cordon ombilical Stewart T 2021 Blood.ca website View Health care providers Benchmarking and standard setting
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques Jenkins C 2018 Blood.ca website View Health care providers Benchmarking and standard setting
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques Jenkins C 2019 Blood.ca website View Health care providers Benchmarking and standard setting
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques Jenkins C 2021 Blood.ca website Health care providers Benchmarking and standard setting
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques Stewart T 2022 Blood.ca website View Health care providers Benchmarking and standard setting
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques Stewart T 2023 Blood.ca website View Health care providers Benchmarking and standard setting
Circulaire d'information utilisation de composants sanguins humains: Concentrés plaquettaires à pathogènes inactivés Stewart T 2022 Blood.ca website View Health care providers Benchmarking and standard setting
Circulaire d'information utilisation de composants sanguins humains: Culot globulaire partiellement déleucocyté (PD) Jenkins C 2021 Blood.ca website Health care providers Benchmarking and standard setting
Circulaire d'information utilisation de composants sanguins humains: Plaquettes Jenkins C 2018 Blood.ca website View Health care providers Benchmarking and standard setting
Circulaire d'information utilisation de composants sanguins humains: Plaquettes Jenkins C 2021 Blood.ca website Health care providers Benchmarking and standard setting
Circulaire d'information utilisation de composants sanguins humains: Plaquettes Stewart T 2022 Blood.ca website View Health care providers Benchmarking and standard setting
Circulaire d'information utilisation de composants sanguins humains: Plaquettes Stewart T 2022 Blood.ca website View Health care providers Benchmarking and standard setting
Circulaire d'information utilisation de composants sanguins humains: Sang total Stewart T 2022 Blood.ca website View Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC) Cord Blood Stewart T 2021 Blood.ca website View Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC), Cord Blood Jenkins C 2015 Blood.ca website View Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Hematopoietic progenitor cells (HPC), cord blood Jenkins C 2020 Blood.ca website View Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC), Cord Blood Jenkins C 2021 Blood.ca website Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC), Cord Blood Stewart T 2022 Blood.ca website View Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Pathogen Reduced Platelet Concentrates Stewart T 2022 Blood.ca website View Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Plasma components Jenkins C 2018 Blood.ca website View Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Plasma components Jenkins C 2018 Blood.ca website View Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Plasma Components Jenkins C 2019 Blood.ca website View Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Plasma components Jenkins C 2021 Blood.ca website Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Plasma Components Stewart T 2022 Blood.ca website View Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Plasma Components Stewart T 2023 Blood.ca website View Health care providers Benchmarking and standard setting
Circular of Information for the use of human blood components: Platelets Jenkins C 2017 Blood.ca website View Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Platelets Jenkins C 2018 Blood.ca website View Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Platelets Jenkins C 2021 Blood.ca website Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Platelets Stewart T 2022 Blood.ca website View Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Platelets Stewart T 2022 Blood.ca website View Health care providers Benchmarking and standard setting
Circular of Information for the use of human blood components: Red Blood Cells, Leukocytes Reduced (LR) Jenkins C 2017 Blood.ca website View Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Red blood cells, Leukocytes Reduced (LR) Jenkins C 2018 Blood.ca website View Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Red blood cells, leukocytes reduced (LR) Jenkins C 2021 Blood.ca website Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Whole Blood Stewart T 2022 Blood.ca website View Health care providers Benchmarking and standard setting
Circulare d'information utilisation de composants sanguins humains: Cellules progénitrices hématopoïétiques de sang de cordon ombilical Jenkins C 2020 Blood.ca website View Health care providers Benchmarking and standard setting
Circulare d'information utilisation de composants sanguins humains: Culot globulaire partiellement déleuccoyté (PD) Jenkins C 2018 Blood.ca website View Health care providers Benchmarking and standard setting
Circulatory Death Determination in Uncontrolled Organ Donors: A Panel Viewpoint Bernat JL, Bleck TP, Blosser SA, Bratton SL, Capron AM, Cornell D, Devita MA, Fulda GJ, Glazier AK, Gries CJ, Mathur M, Nakagawa TA, Shemie SD 2014 Ann Emerg Med View Health care providers Other